Peripheral Stent System

OVERVIEW
Peripheral Stent System
The ZENFLEX¬ peripheral vascular disease stent system is designed to deliver a self-expanding stent to the iliac artery, superficial femoral arteries and/or proximal popliteal arteries via a 6F delivery system.

PRODUCT FEATURES
UNIQUE SPIRAL DESIGN

Excellent flexibility

Superior vascular compliance


EXCELLENT VASCULAR COMPLIANCE

Every 2mm length contains 7 connecting bridges


MICROMESH DESIGN

High radial strength and good fracture resistance

Maximizes vessel patency by decreasing tissue prolapse


GOLD/TANTALUM MARKER

Each end of the stent embedded 6 micro markers

Accurately mark stent ends out and enhances visibility


CONTROLLED RELEASE SYSTEM

One-handed stent deployment

The initial precise positioning followed by well matching quick release

Ergonomic handle with anti-skid tuning dial combines comfortable hand feel and placement accuracy

Compatible with 0.035"guidewire

INDICATIONS
Peripheral Stent System
The ZENFLEX¬ Peripheral Stent System is indicated for improving luminal diameter in the treatment of patients with de novo or restenotic native lesion(s) of the iliac artery, superficial femoral artery and/or proximal popliteal artery with total lesion length up to 150 mm and with a reference vessel diameter ranging from 3 mm to 8 mm.

If you want to know more details of pad stent surgery recovery and leg artery stent surgery, please visit our website.

Zylox-Tonbridge Medical Technology Co., Ltd. ("Zylox-Tonbridge" or "the Company", "2190.HK") announced on February 28 that it has received approval from Hong Kong Stock Exchange, regarding implementation of full circulation of its H shares. The approval was for the conversion and listing of the Company’s 194 million domestic unlisted shares.